Literature DB >> 21323871

Biological evaluation of CpG stimulation of normal human B-cells: implications for B-cell biology and cytogenetic analysis of CLL B-cells.

Xiaosheng Wu, Stephanie A Smoley, Mark A Peterson, Denise K Walters, Bonnie K Arendt, Grzegorz S Nowakowski, Daniel L Van Dyke, Neil E Kay, Diane F Jelinek.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21323871      PMCID： PMC3076335          DOI： 10.1111/j.1365-2141.2010.08514.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  10 in total

Review 1.  Immunotherapeutic uses of CpG oligodeoxynucleotides.

Authors:  Dennis M Klinman
Journal:  Nat Rev Immunol       Date:  2004-04       Impact factor: 53.106

2.  Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia.

Authors:  Christine Mayr; Michael R Speicher; David M Kofler; Raymund Buhmann; John Strehl; Raymonde Busch; Michael Hallek; Clemens-Martin Wendtner
Journal:  Blood       Date:  2005-09-22       Impact factor: 22.113

3.  TOLL-like receptor ligands stimulate aberrant class switch recombination in early B cell precursors.

Authors:  Efrat Edry; Hilla Azulay-Debby; Doron Melamed
Journal:  Int Immunol       Date:  2008-10-29       Impact factor: 4.823

4.  Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping.

Authors:  C Haferlach; F Dicker; S Schnittger; W Kern; T Haferlach
Journal:  Leukemia       Date:  2007-09-06       Impact factor: 11.528

5.  Fluorescent-labeled DNA probes applied to novel biological aspects of B-cell chronic lymphocytic leukemia.

Authors:  Stephanie R Fink; Sarah F Paternoster; Stephanie A Smoley; Heather C Flynn; Susan M Geyer; Tait D Shanafelt; You Kyoung Lee; Diane F Jelinek; Neil E Kay; Gordon W Dewald
Journal:  Leuk Res       Date:  2005-03       Impact factor: 3.156

6.  Role of genomic instability and p53 in AID-induced c-myc-Igh translocations.

Authors:  Almudena R Ramiro; Mila Jankovic; Elsa Callen; Simone Difilippantonio; Hua-Tang Chen; Kevin M McBride; Thomas R Eisenreich; Junjie Chen; Ross A Dickins; Scott W Lowe; Andre Nussenzweig; Michel C Nussenzweig
Journal:  Nature       Date:  2006-01-08       Impact factor: 49.962

7.  Immunostimulatory oligonucleotide-induced metaphase cytogenetics detect chromosomal aberrations in 80% of CLL patients: A study of 132 CLL cases with correlation to FISH, IgVH status, and CD38 expression.

Authors:  Frank Dicker; Susanne Schnittger; Torsten Haferlach; Wolfgang Kern; Claudia Schoch
Journal:  Blood       Date:  2006-07-13       Impact factor: 22.113

8.  AID produces DNA double-strand breaks in non-Ig genes and mature B cell lymphomas with reciprocal chromosome translocations.

Authors:  Davide F Robbiani; Samuel Bunting; Niklas Feldhahn; Anne Bothmer; Jordi Camps; Stephanie Deroubaix; Kevin M McBride; Isaac A Klein; Gary Stone; Thomas R Eisenreich; Thomas Ried; André Nussenzweig; Michel C Nussenzweig
Journal:  Mol Cell       Date:  2009-11-25       Impact factor: 17.970

9.  Improved detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide and interleukin-2 stimulation: A Belgian multicentric study.

Authors:  Natalie Put; Peter Konings; Katrina Rack; Mauricette Jamar; Nadine Van Roy; Jeanne-Marie Libouton; Pascal Vannuffel; Daniel Sartenaer; Geneviève Ameye; Frank Speleman; Christian Herens; Hélène A Poirel; Yves Moreau; Anne Hagemeijer; Peter Vandenberghe; Lucienne Michaux
Journal:  Genes Chromosomes Cancer       Date:  2009-10       Impact factor: 5.006

10.  Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesis.

Authors:  Sandrine Roulland; Jean-Marc Navarro; Pierre Grenot; Michèle Milili; Julie Agopian; Bertrand Montpellier; Pascal Gauduchon; Pierre Lebailly; Claudine Schiff; Bertrand Nadel
Journal:  J Exp Med       Date:  2006-10-16       Impact factor: 14.307
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.